Nevro PE Ratio 2013-2024 | NVRO
Current and historical p/e ratio for Nevro (NVRO) from 2013 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Nevro PE ratio as of November 01, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Nevro PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-10-31 | 5.51 | 0.00 | |
2024-06-30 | 8.42 | $-2.13 | 0.00 |
2024-03-31 | 14.44 | $-2.29 | 0.00 |
2023-12-31 | 21.52 | $-2.57 | 0.00 |
2023-09-30 | 19.22 | $-2.86 | 0.00 |
2023-06-30 | 25.42 | $0.01 | 2542.00 |
2023-03-31 | 36.15 | $-0.01 | 0.00 |
2022-12-31 | 39.60 | $-0.01 | 0.00 |
2022-09-30 | 46.60 | $-0.33 | 0.00 |
2022-06-30 | 43.83 | $-3.99 | 0.00 |
2022-03-31 | 72.33 | $-3.90 | 0.00 |
2021-12-31 | 81.07 | $-3.77 | 0.00 |
2021-09-30 | 116.38 | $-3.12 | 0.00 |
2021-06-30 | 165.79 | $-1.97 | 0.00 |
2021-03-31 | 139.50 | $-2.56 | 0.00 |
2020-12-31 | 173.10 | $-2.49 | 0.00 |
2020-09-30 | 139.30 | $-2.72 | 0.00 |
2020-06-30 | 119.47 | $-3.01 | 0.00 |
2020-03-31 | 99.98 | $-2.71 | 0.00 |
2019-12-31 | 117.54 | $-3.38 | 0.00 |
2019-09-30 | 85.97 | $-3.26 | 0.00 |
2019-06-30 | 64.83 | $-3.05 | 0.00 |
2019-03-31 | 62.51 | $-2.49 | 0.00 |
2018-12-31 | 38.89 | $-1.63 | 0.00 |
2018-09-30 | 57.00 | $-1.46 | 0.00 |
2018-06-30 | 79.85 | $-1.30 | 0.00 |
2018-03-31 | 86.67 | $-1.45 | 0.00 |
2017-12-31 | 69.04 | $-1.20 | 0.00 |
2017-09-30 | 90.88 | $-1.19 | 0.00 |
2017-03-31 | 93.70 | $-1.29 | 0.00 |
2016-12-31 | 72.66 | $-1.12 | 0.00 |
2016-09-30 | 104.39 | $-1.29 | 0.00 |
2016-06-30 | 73.76 | $-1.74 | 0.00 |
2016-03-31 | 56.26 | $-2.20 | 0.00 |
2015-12-31 | 67.51 | $-2.27 | 0.00 |
2014-12-31 | 38.67 | $-2.46 | 0.00 |
2015-06-30 | 53.75 | $-2.44 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.206B | $0.425B |
Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $213.123B | 26.03 |
Intuitive Surgical (ISRG) | United States | $180.348B | 94.29 |
Alcon (ALC) | Switzerland | $45.275B | 31.87 |
Edwards Lifesciences (EW) | United States | $40.686B | 25.30 |
IQVIA Holdings (IQV) | United States | $38.130B | 20.92 |
IDEXX Laboratories (IDXX) | United States | $34.345B | 40.24 |
DexCom (DXCM) | United States | $27.478B | 41.38 |
Waters (WAT) | United States | $22.986B | 34.00 |
STERIS (STE) | Ireland | $22.207B | 25.91 |
SONOVA HOLDING (SONVY) | Switzerland | $21.889B | 0.00 |
Hologic (HOLX) | United States | $19.123B | 20.79 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.596B | 13.00 |
Sysmex ADR (SSMXY) | Japan | $11.505B | 36.08 |
Globus Medical (GMED) | United States | $10.139B | 28.36 |
Teleflex (TFX) | United States | $9.952B | 15.65 |
Penumbra (PEN) | United States | $8.954B | 87.71 |
Masimo (MASI) | United States | $7.672B | 41.09 |
Glaukos (GKOS) | United States | $7.241B | 0.00 |
PROCEPT BioRobotics (PRCT) | United States | $4.816B | 0.00 |
Integer Holdings (ITGR) | United States | $4.241B | 24.04 |
Inari Medical (NARI) | United States | $2.853B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.776B | 16.03 |
TransMedics (TMDX) | United States | $2.766B | 87.66 |
Veracyte (VCYT) | United States | $2.635B | 163.38 |
Nihon Kohden (NHNKY) | Japan | $2.558B | 15.91 |
Elekta AB (EKTAY) | Sweden | $2.267B | 18.47 |
Tandem Diabetes Care (TNDM) | United States | $2.089B | 0.00 |
RxSight (RXST) | United States | $1.890B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.496B | 6.81 |
Alphatec Holdings (ATEC) | United States | $1.150B | 0.00 |
Artivion (AORT) | United States | $1.121B | 102.88 |
OPKO Health (OPK) | United States | $1.053B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.896B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.860B | 14.62 |
Pacific Biosciences Of California (PACB) | United States | $0.665B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.663B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.647B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.638B | 16.12 |
IRadimed (IRMD) | United States | $0.612B | 33.08 |
AxoGen (AXGN) | United States | $0.611B | 0.00 |
SiBone (SIBN) | United States | $0.562B | 0.00 |
Paragon 28 (FNA) | United States | $0.470B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.356B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.349B | 10.64 |
Treace Medical Concepts (TMCI) | United States | $0.297B | 0.00 |
CVRx (CVRX) | United States | $0.292B | 0.00 |
Delcath Systems (DCTH) | United States | $0.292B | 0.00 |
AngioDynamics (ANGO) | United States | $0.271B | 0.00 |
Sight Sciences (SGHT) | United States | $0.262B | 0.00 |
Semler Scientific (SMLR) | United States | $0.215B | 15.04 |
Inogen (INGN) | United States | $0.206B | 0.00 |
NeuroPace (NPCE) | United States | $0.184B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.179B | 0.00 |
Accuray (ARAY) | United States | $0.175B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.124B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.123B | 0.00 |
908 Devices (MASS) | United States | $0.120B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.108B | 16.02 |
EDAP TMS S.A (EDAP) | France | $0.106B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.088B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.080B | 0.00 |
Hyperfine (HYPR) | United States | $0.071B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.067B | 0.00 |
LENSAR (LNSR) | United States | $0.062B | 0.00 |
InspireMD (NSPR) | Israel | $0.062B | 0.00 |
Envoy Medical (COCH) | United States | $0.050B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.047B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.046B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.045B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
Neuronetics (STIM) | United States | $0.031B | 0.00 |
DarioHealth (DRIO) | United States | $0.030B | 0.00 |
Spectral AI (MDAI) | United States | $0.027B | 0.00 |
Precision Optics (POCI) | United States | $0.026B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.018B | 0.00 |
NexGel (NXGL) | United States | $0.018B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.017B | 0.00 | |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.015B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.015B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.013B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.013B | 0.00 |
PAVmed (PAVM) | United States | $0.011B | 0.00 |
Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
Venus Concept (VERO) | Canada | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
Nuwellis (NUWE) | United States | $0.003B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
Tenon Medical (TNON) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Avinger (AVGR) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |